NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Bladder cancer patients get new hope from virus therapy
Disease control CompletedThis study tested a new treatment called VG161, a virus designed to attack cancer cells, in 20 people with a type of bladder cancer that didn't respond to standard therapy. The virus was given directly into the bladder through a tube. The goal was to see if it is safe and if it c…
Matched conditions: NMIBC
Phase 1/2 • Sponsor: Ding-Wei Ye • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New bladder cancer drug shows early promise in small trial
Disease control CompletedThis early-phase trial tested a new drug called UGN-301 (zalifrelimab) given directly into the bladder for people with recurrent non-muscle invasive bladder cancer. The study included 51 participants and aimed to check safety and find the right dose, both alone and with other dru…
Matched conditions: NMIBC
Phase 1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a pill shrink bladder tumors before surgery?
Disease control CompletedThis phase 2 trial tested pemigatinib, a daily pill that blocks certain growth signals, in 30 people with recurrent low- or intermediate-risk non-muscle invasive bladder cancer. Participants took the drug for 4-6 weeks before their standard surgery to remove bladder tumors. The m…
Matched conditions: NMIBC
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can age predict bladder cancer treatment success?
Knowledge-focused CompletedResearchers are investigating whether a patient's age influences the outcomes of BCG therapy for a high-risk form of bladder cancer called pT1 high-grade. This study reviews medical records from 64 patients who received standard BCG treatment after tumor removal. The goal is to c…
Matched conditions: NMIBC
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC